|
1) Wagner HN, Burns HD, Dannals RF, et al. Imaging dopamine receptors in the human brain by positron emission tomography. Science. 1983; 221: 1264-6
|
|
|
|
2) Kung HF, Kung MP, Choi SR. Radiopharmaceuticals for single-photon emission computed tomography brain imaging. Semin Nucl Med. 2003; 33: 2-13
|
|
|
|
|
|
3) 米倉義晴. 脳代謝測定および神経伝達機能評価. In: 上村和夫, 編. 脳のSPECT. 東京: 南江堂; 1999. p. 21-5
|
|
|
|
|
|
4) Johnson EW, Woods SW, Zoghbi S, et al. Receptor binding characterization of the benzodiazepine radioligand 125I-Ro16-0154; potential probe for SPECT brain imaging. Life Sci. 1990; 47: 1535-46
|
|
|
|
|
|
5) Morimoto K, Tamagami H, Matsuda K. Central-type benzodiazepine receptors and epileptogenesis: basic mechanism and clinical validity. Epilepsia. 2005; 46 (Suppl 5): 184-8
|
|
|
|
|
|
6) Sata Y, Matsuda K, Mihara T, et al. Quantitative analysis of benzodiazepine receptor in temporal lobe epilepsy: [125I]iomezenil autoradiographic study of surgically resected specimens. Epilepsia. 2002; 43: 1039-48
|
|
|
|
|
|
7) Goethals I, Van de Wiele C, Boon P, et al. Is central benzodiazepine receptor imaging useful for the identification of epileptogenic foci in localization-related epilepsies？ Eur J Nucl Med Mol Imag. 2003; 30: 325-8
|
|
|
|
|
|
8) 中川原譲二. 神経細胞の画像診断. 分子血管病. 2003; 2: 165-71
|
|
|
|
|
|
9) Dong Y, Fukuyama H, Nabatame H, et al. Assessment of benzodiazepine receptors using iodine-123-labeled iomazenil single-photon emission computed tomography in patients with ischemic cerebrovascular disease: a comparison with PET study. Stroke. 1997; 18: 1776-82
|
|
|
|
|
|
10) Yamashita Y, Matsuishi T, Ishibashi M, et al. Decrease in benzodiazepine receptor binding in the brains of adult patients with Rett syndrome. J Neurol Sci. 1998; 154: 146-50
|
|
|
|
|
|
11) 米倉義晴, 西澤貞彦, 田中富美子, 他. 中枢性ベンジジアゼピン受容体イメージング剤123I-イオマゼニルの第1相臨床試験. 核医学. 1995; 32: 87-97
|
|
|
|
|
12) Onishi Y, Yonekura Y, Nishizawa S, et al. Noninvasive quantification of iodine-123-iomazenil SPECT. J Nucl Med. 1996; 37: 374-8
|
|
|
|
|
|
13) Frey KA, Holthoff VA, Koeppe RA, et al. Parametric in vivo imaging of benzodiazepine receptor distribution in human brain. Ann Neurol. 1991; 30: 663-72
|
|
|
|
|
|
14) Millet P, Graf C, Buck A, et al. Similarity and robustness of PET and SPECT binding parameters for benzodiazepine receptors. J Cereb Blood Flow Metab. 2000; 20: 1587-603
|
|
|
|
|
|
15) Millet P, Graf C, Buck A, et al. Evaluation of the reference tissue models for PET and SPECT benzodiazepine binding parameters. Neuroimage. 2002; 17: 928-42
|
|
|
|
|
|
16) Matheja P, Ludemann P, Kuwert T, et al. Disturbed benzodiazepine receptor function at the onset of temporal lobe epilepsy: iomazenil-binding in de-novo TLE. J Neurol. 2001; 248: 585-91
|
|
|
|
|
|
17) Goethals I, Van de Wiele C, Boon P, et al. Is central benzodiazepine receptor imaging useful for the identification of epileptogenic foci in localization-related epilepsies？ Eur J Nucl Med Mol Imaging. 2003; 30: 325-8
|
|
|
|
|
|
18) Kaneko K, Sasaki M, Morioka T, et al. Pre-surgical identification of epileptogenic areas in temporal lobe epilepsy by 123I-iomazenil SPECT: a comparison with IMP SPECT and FDG PET. Nucl Med Commun. 2006; 27: 893-9
|
|
|
|
|
|
19) Morimoto K, Tamagami H, Matsuda K. Central-type benzodiazepine receptors and epileptogenesis: basic mechanisms and clinical validity. Epilepsia. 2005; 46(Suppl 5): 184-8
|
|
|
|
|
|
20) Matsuda K, Mihara T, Tottori T, et al. Neuroradiographic findings in focal cortical dysplasia: histologic correlation with surgically resected specimens. Epilepsia. 2001; 42(Suppl 6): 29-36
|
|
|
|
|
|
21) Sata Y, Matsuda K, Mihara T, et al. Quantitative analysis of benzodiazepine receptor in temporal lobe epilepsy: [(125I)]iomazenil autoradiographic study of surgically resected specimens. Epilepsia. 2002; 43: 1039-48
|
|
|
|
|
|
22) Makino K, Kamiyama H, Takamura H, et al. Assessment of outcome by EC/IC bypass with 123I-iomazenil brain SPECT. Ann Nucl Med. 1999; 13: 261-4
|
|
|
|
|
|
23) Tsuchida T, Yonekura Y, Sadato N, et al. Prediction of improvement of cerebral perfusion with I-123 iomazenil SPECT. Ann Nucl Med. 1999; 13: 265-8
|
|
|
|
|
|
24) Watanabe Y, Nakano T, Yutani K, et al. Detection of viable cortical neurons using benzodiazepine receptor imaging after reversible focal ischemia in rats: comparison with regional cerebral blood flow. Eur J Nucl Med. 2000; 27: 308-13
|
|
|
|
|
|
25) Saur D, Buchert R, Knab R, et al. Iomazenil-single-photon emission computed tomography reveals selective neuronal loss in magnetic resonance-defined mismatch areas. Stroke. 1996; 37: 2713-9
|
|
|
|
|
|
26) Nakagawara J, Sperling B, Lassen NA. Incomplete brain infarction of reperfused cortex may be quantitated with iomazenil. Stroke. 1997; 28: 124-32
|
|
|
|
|
|
27) Yamauchi H, Fukuyama H, Dong H, et al. Atrophy of the corpus callosum associated with a decrease in cortical benzodiazepine receptor in large arterial occlusive diseases. J Neurol Neurosurg Psychiatry. 2000; 68: 317-22
|
|
|
|
|
|
28) Yamauchi H, Kudoh T, Kishibe Y, et al. Selective neuronal damage and borderzone infarction in carotid artery occlusive disease: a 11C-flumazenil PET study. J Nucl Med. 2005; 46: 1973-9
|
|
|
|
|
|
29) Ishibashi M, Sakai T, Matsuishi T, et al. Decreased benzodiazepine receptor binding in Machado-Joseph disease. J Nucl Med. 1998; 39: 1518-20
|
|
|
|
|
|
30) Ohyama M, Senda M, Ishiwata K, et al. Preserved benzodiazepine receptors in Alzheimer's disease measured with C-11 flumaznil PET and I-123 iomazenil SPECT in comparison with CBF. Ann Nucl Med. 1999; 13: 309-15
|
|
|
|
|
|
31) Fujita M, Woods SW, Verhoeff NP, et al. Changes of benzodiazepine receptors during chronic benzodiazepine administration in humans. Eur J Pharmacol. 1999; 368: 161-72
|
|
|
|
|
|
32) Staley JK, Gottschalk C, Petrakis IL. Cortical gamma-aminobutyric acid type A-benzodiazepine receptors in recovery from alcohol dependence: relationship to features of alcohol dependence and cigarette smoking. Arch Gen Psychiatry. 2005; 62: 877-88
|
|
|
|
|
|
33) Fukumitsu N, Tsuchida D, Ogi S, et al. 125I- iomazenil-benzodiazepine receptor binding during psychological stress in rats. Ann Nucl Med. 2002; 16: 231-5
|
|
|
|
|
|
34) Bremner JD, Innis RB, Southwick SM, et al. Decreased benzodiazepine receptor binding in prefrontal cortex in combat-related posttraumatic stress disorder. Am J Psychiatry. 2000; 157: 1120-6
|
|
|
|
|
|
35) Bremner JD, Innis RB, White T, et al. SPECT [I-123]iomazenil measurement of the benzodiazepine receptor in panic disorder. Biol Psychiatry. 2000; 47: 96-106
|
|
|
|
|
|
36) Verhoeff NP, Soares JC, D'Souza CD, et al. [123I]Iomazenil SPECT benzodiazepine receptor imaging in schizophrenia. Psychiatry Res. 1999; 91: 163-73
|
|
|
|
|